The targeted medication safety best practice for hospitals #13, eliminating injectable promethazine from the formulary, will be discussed. Faculty will describe the process used at one health system to address this safety recommendation. Hear tips that you can apply to your practice.
SPEAKERS
Dr. Meghan Rowcliffe is the Pediatric Medication Safety Officer at the Johns Hopkins Hospital. After graduating from pharmacy school at the University at Buffalo, she completed two years of residency training at Yale-New Haven Hospital. In her position as medication safety officer, Meghan participates in efforts designed to help prevent errors before they occur and contributes to the investigation of actual errors and near misses. Meghan has served on the ASHP Medication Safety Section Advisory Group since 2015.
Rutvik Joshi, PharmD, BCPS, graduated from the Doctor of Pharmacy program of the Ohio State University’s College of Pharmacy. During pharmacy school, he worked as a medication safety intern at the James Cancer Center. He then completed first-year residency in pharmacy practice from University of Utah Health and a second-year residency in Medication-Use Safety and Policy from the Johns Hopkins Hospital. He currently works as the Medication Safety and Compliance Coordinator at the Moffitt Cancer Center.
Erika Lutz Thomas, M.B.A., B.S.Pharm., is the Director of the ASHP Section of Inpatient Care Practitioners. In this role, Ms. Thomas serves as staff liaison to the Section of Inpatient Care Practitioners Executive Committee. She also acts as an ASHP information resource and provides guidance to ASHP members on pharmacy practice in various inpatient care environments in hospitals and health systems, including medication safety, small and rural hospitals, compounding practice, and precepting for pharmacy practice experiences. She also serves as Co-Secretary to the ASHP Council on Education and Workforce Development.